|
|
||||||||
Basic Science Investigations |
1 Chemistry Department, Brookhaven National Laboratory, Upton, New York
2 Medical Department, Brookhaven National Laboratory, Upton, New York
3 Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York
4 Department of Applied Mathematics and Statistics, State University of New York at Stony Brook, Stony Brook, Stony Brook, New York
A new generation of commercial animal PET cameras may accelerate drug development by streamlining preclinical testing in laboratory animals. However, little information on the feasibility of using these machines for quantitative PET in small animals is available. Here we investigate the reproducibility of microPET imaging of 11C-raclopride in the rat brain and the effects of tracer-specific activity and photon scatter correction on measures of D2 receptor (D2R) availability. Methods: Sprague-Dawley rats (422 ± 29 g; n = 7) were anesthetized with ketamine/xylazine and catheterized for tail vein injection of 11C-raclopride. Each animal was positioned prone in the microPET, centering the head in the field of view. MicroPET data was collected for 60 minstarting at 11C-raclopride injectionand binned into 24 time frames (6 x 10 s, 3 x 20 s, 8 x 60 s, 4 x 200 s, 3 x 600 s). In 3 studies, 11C-raclopride was administered a second time in the same animal, with 24 h between injections. In a fourth animal, raclopride (1 mg/kg) was coinjected with 11C-raclopride for the second injection. Three rats received a single dose of 11C-raclopride. The range of doses for all studies was 6.1118.54 MBq (165501 µCi). The specific activity at injection was 4.0748.1 GBq/µmol (0.111.3 Ci/µmol). Region-of-interest analysis was performed and the distribution volume ratio (DVR) was computed for striatum/cerebellum using sinograms uncorrected and corrected for scatter using a tail-fit method. Results: Test-retest results showed that the 11C-raclopride microPET DVR was reproducible (change in DVR = -8.3% ± 4.4%). The average DVR from 6 rats injected with high specific activity (<4 nmol/kg) was 2.43 ± 0.19 (coefficient of variation = 8%). The DVR for the blocking study was 1.23. The DVR depended on the mass of tracer 11C-raclopride injected for doses >1.5 nmol/kg. Scatter fractions within the rat head were
25%45% resulting in an average increase of DVR of 3.5% (range, 0%10%) after correction. Conclusion: This study shows that the 11C-raclopride microPET-derived DVR is reproducible and suitable for studying D2R availability in the rat brain. MicroPET sensitivity was sufficient to determine reproducible DVRs from 11C-raclopride injections of 9.25 MBq (
250 µCi). However, the effect of tracer mass on the DVR should be considered for studies using more than
12 nmol/kg raclopride, and scatter correction has a measurable impact on the results.
Key Words: microPET rat brain dopamine receptor raclopride
This article has been cited by other articles:
![]() |
J. A. Rodriguez-Gomez, J.-Q. Lu, I. Velasco, S. Rivera, S. S. Zoghbi, J.-S. Liow, J. L. Musachio, F. T. Chin, H. Toyama, J. Seidel, et al. Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease Stem Cells, April 1, 2007; 25(4): 918 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Schiffer, M. M. Mirrione, and S. L. Dewey Optimizing Experimental Protocols for Quantitative Behavioral Imaging with 18F-FDG in Rodents J. Nucl. Med., February 1, 2007; 48(2): 277 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casteels, P. Vermaelen, J. Nuyts, A. Van Der Linden, V. Baekelandt, L. Mortelmans, G. Bormans, and K. Van Laere Construction and Evaluation of Multitracer Small-Animal PET Probabilistic Atlases for Voxel-Based Functional Mapping of the Rat Brain J. Nucl. Med., November 1, 2006; 47(11): 1858 - 1866. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |